This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,438.37, is for the delivery of TWINRIX VACCINE SYRINGEML, a vaccine product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.14 firm fixed-price delivery order is for the supply of TWINRIX vaccine syringes. The contract has an ultimate completion date of November 8, 2024 and was awarded on November 7, 2024. This appears to be a component of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of TWINRIX VACCINE SYRINGEML. The $2,156.48 firm fixed-price delivery order has an ultimate completion date of January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,249.30 firm-fixed-price delivery order is for the provision of TWINRIX vaccine syringes. The contract has an ultimate completion date of June 17, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,048.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the TWINRIX vaccine in syringe form, a pharmaceutical product used for immunization. The contract has a firm fixed-price structure and is a delivery order with a completion date of May 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA...
This federal contract award, valued at $2,584.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of TWINRIX vaccine syringes. The contract has a period of performance through July 30, 2024 and is a firm fixed-price delivery order. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $241,094.42, is for the delivery of the TWINRIX vaccine in syringes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,184.49 firm fixed-price delivery order is for the supply of TWINRIX vaccine syringes. The contract has an ultimate completion date of May 3, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $53,439.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a medical product, with a period of performance through January 16, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside program. Additionally, AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,747.52 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEML, with a period of performance through May 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...